1-3 of 3
Annet Z Vos
Close
Sort by
Journal Articles

Loss of Stem Cell Quiescence and Impaired Stem Cell Function of CD34 + /CD38 low Cells One Year Following Autologous Stem Cell Transplantation

Carolien M Woolthuis, Annet Z Vos, Gerwin Huls, Joost TM de Wolf, Jan J. Schuringa, PhD, Edo Vellenga, PhD
Journal: Blood
Blood (2011) 118 (21): 1893.
https://doi.org/10.1182/blood.V118.21.1893.1893
Published: 2011
Journal Articles

Gene Expression Profiling In Leukemic Stem Cell-Enriched AML CD34 + Cell Fraction Identifies Target Genes That Predict Prognosis In Normal Karyotype AML

Carolien M Woolthuis, Hendrik JM de Jonge, Annet Z Vos, Andre B Mulder, MD, Eva van den Berg, P.M. Kluin, MD, PhD, Karen van der Weide, Evelina S. De Bont, MD, PhD, Geert A Huls, MD, PhD, Edo Vellenga, MD, PhD, Jan J. Schuringa, PhD
Journal: Blood
Blood (2010) 116 (21): 952.
https://doi.org/10.1182/blood.V116.21.952.952
Published: 2010
Journal Articles

Autologous Stem Cell Transplantation Induces a Phenotypical Shift From CMP to GMP Progenitors, Reduces Clonogenic Potential and Enhances in Vitro and In Vivo Cycling Activity Defined by 18 f-FLT PET Scan.

Carolien M. Woolthuis, Ali Agool, Annet Z. Vos, Riemert H.J.A. Slart, MD, PhD, Geert A. Huls, MD, PhD, W. Martin Smid, MD, PhD, Jan Jacob Schuringa, PhD, Edo Vellenga, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 4473.
https://doi.org/10.1182/blood.V114.22.4473.4473
Published: 2009